Acoltremon Ophthalmic Solution 0.003% for Signs and Symptoms of Dry Eye Disease: Results of Phase 3 Pivotal Studies COMET-2 and COMET-3

Journal:

Ophthalmology

Published:

2025-10-02

DOI:

10.1016/j.ophtha.2025.09.018

Affiliations:

11

Authors:

13

Go to article

Institutions	Authors	Share
Total Eye Care, United States of America (USA)	2.090909	0.16
Alcon Inc., United States of America (USA)	1.090909	0.08
CORE, United States of America (USA)	1.090909	0.08
Piedmont Eye Center, United States of America (USA)	1.090909	0.08
University of New England (UNE), United States of America (USA)	1.090909	0.08
Eye Research Foundation, United States of America (USA)	1.090909	0.08
Advancing Vision Research, United States of America (USA)	1.090909	0.08
NVISION Clinical Research, United States of America (USA)	1.090909	0.08
Andover Eye, United States of America (USA)	1.090909	0.08
Triangle Eye Consultants, United States of America (USA)	1.090909	0.08
Butchertown Clinical Trials, United States of America (USA)	1.090909	0.08

Interested in Ophthalmology and Optometry?